Lindbrook Capital, LLC Novo Nordisk A S Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Lindbrook Capital, LLC holds 10,735 shares of NVO stock, worth $937,916. This represents 0.11% of its overall portfolio holdings.

Number of Shares

10,735

Previous 10,389 3.33%

Holding current value

$937,916

Previous $1.48 Million 13.77%

% of portfolio

0.11%

Previous 0.14%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$119.07 - $145.42 $41,198 - $50,315	346 Added 3.33%	10,735 $1.28 Million
Q2 2024 Jul 31, 2024	BUY	$122.71 - $146.91 $33,254 - $39,812	271 Added 2.68%	10,389 $1.48 Million
Q1 2024 Apr 25, 2024	BUY	$102.11 - $135.92 $23,587 - $31,397	231 Added 2.34%	10,118 $1.3 Million
Q4 2023 Jan 31, 2024	SELL	$87.78 - $105.45 $15,800 - $18,981	-180 Reduced 1.79%	9,887 $1.02 Million
Q3 2023 Oct 25, 2023	BUY	$90.94 - $199.54 $469,341 - $1.03 Million	5,161 Added 105.2%	10,067 $915,000
Q2 2023 Jul 28, 2023	BUY	$155.98 - $172.65 $1,247 - $1,381	8 Added 0.16%	4,906 $793,000
Q1 2023 Apr 26, 2023	BUY	$132.34 - $159.14 $4,896 - $5,888	37 Added 0.76%	4,898 $779,000
Q4 2022 Jan 24, 2023	BUY	$102.55 - $135.33 $19,381 - $25,577	189 Added 4.05%	4,861 $0
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $2,667 - $3,274	28 Added 0.6%	4,672 $465,000
Q2 2022 Aug 01, 2022	BUY	$103.24 - $121.81 $88,476 - $104,391	857 Added 22.63%	4,644 $517,000
Q1 2022 Apr 21, 2022	SELL	$93.1 - $112.54 $4,561 - $5,514	-49 Reduced 1.28%	3,787 $421,000
Q4 2021 Jan 18, 2022	BUY	$95.88 - $117.08 $17,066 - $20,840	178 Added 4.87%	3,836 $430,000
Q3 2021 Nov 05, 2021	BUY	$84.42 - $106.62 $5,656 - $7,143	67 Added 1.87%	3,658 $351,000
Q2 2021 Jul 27, 2021	SELL	$67.66 - $84.76 $5,954 - $7,458	-88 Reduced 2.39%	3,591 $301,000
Q1 2021 Apr 28, 2021	BUY	$67.06 - $75.82 $25,616 - $28,963	382 Added 11.59%	3,679 $248,000
Q4 2020 Jan 27, 2021	BUY	$63.89 - $73.8 $3,130 - $3,616	49 Added 1.51%	3,297 $230,000
Q3 2020 Nov 03, 2020	SELL	$63.69 - $70.22 $700 - $772	-11 Reduced 0.34%	3,248 $226,000
Q2 2020 Jul 27, 2020	BUY	$58.54 - $67.94 $8,781 - $10,191	150 Added 4.82%	3,259 $213,000
Q1 2020 Apr 22, 2020	SELL	$49.46 - $64.78 $45,750 - $59,921	-925 Reduced 22.93%	3,109 $187,000
Q4 2019 Jan 27, 2020	SELL	$49.86 - $58.26 $2,792 - $3,262	-56 Reduced 1.37%	4,034 $233,000
Q3 2019 Oct 31, 2019	SELL	$47.54 - $53.43 $3,755 - $4,220	-79 Reduced 1.89%	4,090 $211,000
Q2 2019 Jul 24, 2019	BUY	$46.79 - $52.47 $9,404 - $10,546	201 Added 5.07%	4,169 $212,000
Q1 2019 Apr 23, 2019	BUY	$46.36 - $52.63 $8,437 - $9,578	182 Added 4.81%	3,968 $207,000
Q4 2018 Feb 07, 2019	BUY	$41.54 - $47.25 $157,270 - $178,888	3,786 New	3,786 $174,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Novo Nordisk A S Transaction History